XML 19 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

The following tables set forth the fair value of the Company’s financial assets measured at fair value on a recurring basis and indicates the level within the fair value hierarchy utilized to determine such values (in thousands):

 

As of March 31, 2024

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

     U.S. Treasury backed money market funds

 

$

143,427

 

 

$

143,427

 

 

$

 

 

$

 

     U.S. Treasury securities

 

 

4,977

 

 

 

4,977

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

     U.S. Treasury securities

 

 

171,339

 

 

 

171,339

 

 

 

 

 

 

 

Total

 

$

319,743

 

 

$

319,743

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2023

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

     U.S. Treasury backed money market funds

 

$

99,388

 

 

$

99,388

 

 

$

 

 

$

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

     U.S. Treasury securities

 

 

153,007

 

 

 

153,007

 

 

 

 

 

 

 

Total

 

$

252,395

 

 

$

252,395

 

 

$

 

 

$

 

 

CVR asset and liability

Upon the completion of the Merger in February 2023, the Company assessed the fair value of the payments to be made under the CVR Agreement to be zero as the Company had determined the payments were not probable. During the fourth quarter of 2023, the Company assessed the fair value of the first milestone under the asset purchase agreement at 100% based upon certain information received from the third-party indicating that the milestone was likely to be achieved in early 2024. As such, the Company estimated the fair value of the CVR asset and liability for this first milestone and recorded a $10.0 million CVR asset and $10.0 million CVR liability on its consolidated balance sheet as of December 31, 2023. In March 2024, the Company received formal notification from the third-party that the first milestone event as set forth in the asset purchase agreement had been achieved, and the Company

received the $10.0 million milestone payment in April 2024. As the second milestone event under this asset purchase agreement relates to the future potential commercialization of the assets, no value was attributed to this milestone as of March 31, 2024 and December 31, 2023. As of March 31, 2024 and December 31, 2023, the Company's condensed consolidated balance sheets reflected a $10.0 million CVR asset and $10.0 million CVR liability, and no CVR payments have been made under the CVR Agreement. Pursuant to the terms of the CVR Agreement, the Company has 45 days from the end of the calendar quarter in which funds are received to deliver the milestone proceeds, net of permitted deductions, if any, to the rights agent for distribution to the CVR holders.